The collection, control, storage, traceability and transport of faeces carried out by the establishments or organisations mentioned inArticle L. 513-11-1, including in the context of research involving the human person, are carried out in accordance with the rules of good practice defined by decision of the Director General of the Agence nationale de sécurité du médicament et des produits de santé. These rules of good practice include in particular the clinical and biological selection rules applicable to the collection of faeces.
The importation of faeces intended for the preparation of faecal microbiota for therapeutic purposes and the importation of preparations of faecal microbiota are subject to authorisation issued by the Agence nationale de sécurité du médicament et des produits de santé.